A PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBOCONTROLLED, DOSE-RESPONSE STUDY OF SAGE-324 FOR THE TREATMENT OF ESSENTIAL TREMOR

Project: Clinical Trial

Project Details

StatusNot started